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Abstract
Background: The triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) has been advocated as a
simple clinical indicator of insulin resistance. Thresholds of TG/HDL-C appeared to depend on ethnicity. However,
no studies have specifically compared the accuracy of TG/HDL-C with and without other clinical and demographic
factors in predicting insulin resistance in Taiwanese adults. The aim of the present investigation was to use TG/
HDL-C and other clinical available factors to predict insulin resistance in Taiwanese adults.
Methods: A total of 812 subjects were recruited from at the time of their general health examination at the
Buddhist Dalin Tzu Chi General Hospital, Taiwan. Demographic information and clinical characteristics were
obtained. Insulin resistance was defined by the homeostasis model assessment for insulin resistance (HOMA-IR).
Simple and multiple logistic regression analyses were used to obtain probabilities of insulin resistance (HOMA-IR >
2) using TG/HDL-C with (Model 2) and without (Model 1) other clinical variables. A receiver operating characteristic
(ROC) analysis was conducted to evaluate the ability of the two models to correctly discriminate between subjects
of low and elevated HOMA-IR.
Results: Female sex, greater waist circumferences, and higher ALT levels were significantly associated with the risk
of elevated HOMA-IR in addition to TG/HDL-C in the multiple logistic regression (Model 2). The area under the ROC
curve (AUC) of Model 2 was 0.71 [95% CI = 0.67-0.75] and was significantly higher (P = 0.007) than the AUC 0.66
[95% CI = 0.62-0.71] of Model 1.
Conclusions: The diagnostic accuracy of insulin resistance, defined by HOMA-IR, using TG/HDL-C can be
significantly enhanced by including three additional clinically available factors - sex, waist circumferences, and ALT
levels.
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Background
Metabolic syndrome is characteristically defined as a
clustering condition of cardiovascular risk factors
including hyperglycemia, dyslipidemia, hypertension,
and central obesity [1]. Its occurrence is strongly asso-
ciated with increased risk in the development of diabetes
and cardiovascular disease. A recent meta-analysis of 87
prospective observational studies reported that meta-
bolic syndrome was associated with a two-fold increase
in cardiovascular disease outcomes and a 50% increase
in risk of all-cause mortality [2].
The pathophysiology of the metabolic syndrome
remains a subject of controversy but many of its features
are associated with insulin resistance. It is typically
defined as decreased sensitivity or responsiveness to
metabolic actions of insulin. Currently, there are several
directly and indirect methods to assess insulin resistance
[3]. The gold standard method was the hyperinsuline-
mic-euglycemic clamp (glucose clamp) technique, ori-
ginally developed by DeFronzo [4]. However, the
method is complex and time consuming, making it not
feasible for either epidemiological investigations or
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any medium, provided the original work is properly cited.routine clinical applications. Therefore, a number of sur-
rogate indices of insulin resistance have been developed.
Previous studies have shown that insulin resistance
scores based on the homeostasis model assessment
(HOMA) method was strongly correlated with glucose
clamp-assessed insulin resistance [5,6]. The model uti-
lize a set of empirically derived nonlinear equations to
predict the homeostatic concentrations of fasting insulin
and glucose, which reflect the varying degrees of pan-
creatic b-cell function and insulin resistance [7].
Although HOMR-IR has been widely used in the
study of metabolic syndrome, the lack of standardized
insulin assay has limited its clinical utility [8]. It would
be of considerable benefit for clinicians if other standar-
dized measures are available for predicting insulin resis-
tance without the need for direct measurements of
fasting insulin. Since hypertriglyceridemia and low high-
density lipoprotein cholesterol are two key metabolic
abnormalities associated with insulin resistance states
[9,10], the triglyceride to high-density lipoprotein cho-
lesterol ratio (TG/HDL-C) has been advocated as a sim-
ple clinical indicator of insulin resistance [11,12]. It has
been evaluated as predictor of diabetes [13] and coron-
ary heart disease [14]. In a cohort study on 3,014
patients, the area under the receiver operating charac-
teristic curves (AUC) for predicting insulin resistance
with TG/HDL-C was 0.75 [14]. Nevertheless, recent stu-
dies have reported that racial differences existed in the
predictability of the ratio [15]. In a cross-sectional study
of 50 white and 99 African American adults, the AUCs
of TG/HDL-C for predicting insulin resistance, as mea-
s u r e db yH O M A - I R ,w a sf o u n dt ob e0 . 7 7a n d0 . 6 4 ,
respectively. It was concluded that the relationship
between TG/HDL-C and insulin resistance varied in dif-
ferent ethnic groups and TG/HDL-C was not a reliable
marker for predicting insulin resistance in African
Americans [16]. On the other hand, a cross-sectional
study of 6,546 Korean adults who underwent routine
health examinations foundt h a tT G / H D L - Cw a sac o n -
sistent indicator of insulin resistance in subjects without
metabolic syndrome [17].
In addition, depending on ethnicity, different thresh-
olds of TG/HDL-C have been proposed for predicting
insulin resistance. A ratio of 3.0 was suggested for non-
Hispanic whites and Mexican Americans, 2.0 for non-
Hispanic blacks [18], and 2.5 for African-American men
[19]. Despite of numerous studies have evaluated the
optimal threshold for TG/HDL-C, to the best of our
knowledge, no studies have specifically compared the
accuracy of TG/HDL-C with and without other clinical
and demographic factors in predicting insulin resistance.
Moreover, no studies have reported that prediction of
insulin resistance using TG/HDL-C in Taiwanese adults.
Hence, the aim of this study was to evaluate the
prediction of insulin resistance by TG/HDL-C with and
without the inclusion of other clinical available factors
for clinical applications.
Methods
Study Subjects
Participants were recruited at the time of their general
health examination at the Buddhist Dalin Tzu Chi Gen-
eral Hospital located in Chiayi county, Taiwan between
May 2007 and April 2008. The study hospital is located
in south Taiwan and most of the participants came
from Yulin, Chiayi, Tainan, and Kaoshiung counties in
southern Taiwan.
This study was approved by the Institutional Review
Board of the study hospital and written informed con-
sent was given by all the participants before enrollment.
Information on demographic and clinical characteris-
tics including age, sex, location of residence, weight,
height, waist circumference, and sitting blood pressure
were collected. Body mass index was calculated by divid-
ing weight (in kilograms) by the square of the height (in
meters). Daily energy expenditure was estimated using a
seven-day physical activity recall questionnaire (Chinese
version) [20].
Sample processing and analyses
Triglyceride, total cholesterol, HDL-C, LDL-C, glucose,
insulin, and alaninne aminotrasferase (ALT) were mea-
sured using blood sample collected from each subject
after a minimum eight hour fasting period. Plasma
fasting insulin concentrations were measured using
human insulin Enzyme Linked Immunosorbent Assay
(ELISA) kit (BioSource Europe S.A., Nivelles, Belgium).
Insulin resistance was defined by homeostasis model
assessment for insulin resistance (HOMA-IR). HOMA-
IR was calculated by dividing the product of fasting
plasma glucose (mg/dL) and fasting plasma insulin
(mU/L) by 405 [5]. Other biochemical variables includ-
ing blood lipids, and glucose were analyzed using an
auto-analyzer (Sysmex XE-2100 Blood Cell Analyzer,
Kobe, Japan).
Statistical Analyses
Statistical analysis was performed using the R,v e r s i o n
2.12.1, software (Free Software Foundation, Inc., Boston,
MA, U.S.A.). Subjects were divided into elevated
HOMA-IR and low HOMA-IR groups using a cutoff
value of 2. Two-sided p value ≤ 0.05 was considered sta-
tistically significant. Continuous data were expressed as
mean ± standard deviation (SD) and categorical vari-
ables were represented by frequency and percentage.
Differences in demographic and clinical characteristics
of subjects between the low and elevated HOMA-IR
groups were examined using the two-sample t test for
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cal variables.
Simple logistic regression was used to obtain probabil-
ity of insulin resistance (HOMA-IR > 2) using only TG/
HDL-C (Model 1). Multiple logistic regression analysis
with stepwise variable selection procedure using the
Akaike’s Information Criterion (AIC) was also con-
ducted to evaluate other factors that were significantly
associated with insulin resistance in addition to TG/
HDL-C (Model 2). A ROC analysis was conducted to
evaluate the ability of the two models for correctly dis-
criminating the subjects of low and elevated HOMA-IR.
Plots of the sensitivity (true positive) versus 1-specificity
(false positive) for the two models were made and the
overall diagnostic accuracy between the two models was
quantified using AUC. These two correlated ROC curves
were then compared by applying the ROC test of
DeLong using the roc.test function of the pROC library
in R.
Results
A total of 812 subjects were recruited into the study
after excluding 8 subjects using lipid-lowering medica-
tions, 53 subjects using antidiabetic medications, and 4
using both types of medications. Table 1 shows the
demographic and clinical characteristics of subjects cate-
gorized by HOMA-IR using a cutoff value of 2. The
subjects comprised of 403 men aged 52.0 ± 11.0 [range
22.0-80.5] years and 409 women aged 52.1 ± 9.8 [range
19.3-81.5]. There were no significant differences in age,
sex, location of residence, body height, total cholesterol
levels, low-density lipoprotein-cholesterol (LDL-C)
levels, and daily energy expenditure between the two
HOMA-IR groups. The mean body weight, body mass
index, waist circumference, systolic blood pressure, dia-
stolic blood pressure, fasting glucose level, triglyceride
level, alanine transaminase (ALT) level, and insulin level
were significantly higher in the elevated HOMA-IR
group. The mean high density lipoprotein-cholesterol
(HDL-C) level was significantly lower in the elevated
HOMA-IR group.
Table 2 shows the two models of the association
between TG/HDL-C and HOMA-IR. Model 1 contained
only TG/HDL-C as a predictor and Model 2 contained
covariates in addition to TG/HDL-C that were obtained
from stepwise multiple logistic regression. Female sex,
greater waist circumferences, higher ALT levels, and
higher TG/HDL-C were significantly associated with the
prevalence odds of elevated HOMA-IR. In Model 1, an
increase of 1 unit in TG/HDL-C ratio was associated
with an elevation in the insulin resistance by 31% while
in Model 2, the corresponding in the TG/HDL ratio was
associated with an 19% elevation in the odds. Figure 1
shows the ROC curves between the two models. The
AUC of Model 2 was 0.71 [95% CI = 0.67-0.75], which
was significantly higher (P = 0.007) than the AUC 0.66
[95% CI = 0.62-0.71] of Model 1. The codes for calculat-
ing the probability of elevated insulin resistance using
Model 2 in the R environment, Microsoft Excel, and
OpenOffice Calc are provided in Appendix 1. Note that
the model should only be applied to ranges within the
observed values, i.e., waist circumference between 57.1
cm and 111.8 cm, ALT between 8 mg/dL and 526 mg/
dL, and TG/HDL-C ratio between 0.26 and 22.26.
Discussion
This study aimed to develop a simple predictive model
as a clinical tool for evaluation of insulin resistance. In
clinical settings, it would be useful to identify individuals
with insulin resistance using only routinely collected
blood test results such as triglyceride and high-density
lipoprotein cholesterol. Hence, we proposed the predic-
tion of insulin resistance by the ratio of TG and HDL-C.
Table 1 Demographic and clinical characteristics of
subjects categorized by HOMA-IR (N = 812)
Variable HOMA-IR
≤ 2
n = 593
HOMA-IR
>2
n = 219
P
Age (years) 51.8 ± 10.3 52.9 ± 10.6 0.177
Sex
Male 290 (48.9)
† 113 (51.6) 0.496
Female 303 (51.1) 106 (48.4)
Location of residence
Metropolitan 240 (40.5) 90 (41.3)
‡ 0.835
Other 353 (59.5) 128 (58.7)
Body weight (kg) 61.6 ± 9.99 66.4 ± 12.4 < 0.001
Body height (cm) 161.9 ± 8.1 161.8 ± 8.0 0.799
Body mass index (kg/m
2) 23.4 ± 2.9 25.3 ± 3.8 < 0.001
Waist circumference (cm) 76.9 ± 8.3 82.5 ± 10.0 < 0.001
Systolic blood pressure (mmHg) 125.3 ± 18.8 129.0 ± 19.8 0.014
Diastolic blood pressure
(mmHg)
73.6 ± 12.1 76.6 ± 12.0 0.002
Fasting glucose (mg/dL) 88.5 ± 10.0 93.6 ± 11.7 < 0.001
Triglyceride (mg/dL) 102.9 ± 59.5 137.1 ± 79.9 < 0.001
Total cholesterol (mg/dL) 192.7 ± 34.4 192.6 ± 38.2 0.968
HDL-C (mg/dL) 56.3 ± 14.8 50.5 ± 14.3 < 0.001
LDL-C (mg/dL) 127.5 ± 31.6 128.4 ± 35.3 0.738
Insulin (mU/L) 4.84 ± 2.06 15.66 ± 10.32 < 0.001
ALT (mg/dL) 24.2 ± 15.8 38.1 ± 50.2 < 0.001
Energy expenditure (Kcal×10
3/
day)
2.96 ± 1.43 3.03 ± 1.12 0.517
* Continuous variables were represented by mean ± standard deviation.
† Categorical variables were expressed as number (percentage).
‡ One missing data for HOMA-IR > 2 in location of residence.
HDL-C: high-density lipoprotein-cholesterol
LDL-C: low-density lipoprotein-cholesterol
ALT: alanine transaminase
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ated the accuracy of prediction of insulin resistance
using TG/HDL-C with or without the presence of other
readily available demographic and biochemical variables.
The model that included three factors in addition to
TG/HDL-C significantly increased the predicting prob-
ability of higher insulin resistance compared with the
model containing only TG/HDL-C. The three additional
factors were sex, waist circumferences, and ALT levels,
which are readily available measurements in clinical
settings.
Previous studies had used different cutoff values of
TG/HDL-C to predict insulin resistance. However, the
results were inconclusive. The cutoff point for TG/
HDL-C appeared to vary among different ethnic groups.
It was reported to be 3.0 for non-Hispanic whites and
Mexican Americans and 2.0 for non-Hispanic blacks
[18]. In contrast to these studies, the present study did
not use a cutoff point for TG/HDL-C to predict insulin
resistance. Instead, we treated TG/HDL-C as a continu-
ous variable to predict the probability of insulin resis-
t a n c ea sm e a s u r e db yH O M A - I R .I nas t u d yo f1 , 8 2 4
Iranian men of age 40 years and above, it was reported
that the prevalence of metabolic syndrome in subjects
with TG/HDL-C greater or equal to 6.9 was 63.6%,
compared with 3.0% in those with TG/HDL-C below 2.8
[21]. The risk of metabolic syndrome appeared to be
incrementally associated with TG/HDL-C and there are
no consensual cutoff values for it. Therefore, no cutoff
point was set for TG/HDL-C in the present study.
In addition to the potential use as a predictor of insu-
lin resistance in clinical settings, the ratio of TG and
HDL-C has also been reported as a strong predictor of
incident hypertension in a prospective study of 2831
non-hypertensive Middle Eastern women [22]. In addi-
tion, based on the findings from a study of 585 males
with type 2 diabetes mellitus, log(TG)/HDL-C was sug-
gested to be used as a simple means of estimating
atherogenic dyslipidemia, which is closely associated
w i t ht h ef u t u r er i s ko fc o r o n a r ya r t e r yd i s e a s e[ 2 3 ] .
Moreover, in a prospective study of a nationally repre-
sentative sample of United States adults with diagnosed
diabetes, higher serum non-HDL-c concentrations was
found to be associated with increased risk of death from
cardiovascular diseases [24]. In our study, higher serum
non-HDL-c levels were directly and significantly corre-
lated with levels of TG/HDL-C, with a Pearson correla-
tion coefficient of 0.34.
There are potential limitations regarding the interpre-
tation of our results. First, previous research found that
ethnicity affects the associations between TG/HDL-C
and insulin resistance. The accuracy of the obtained
Table 2 Two logistic regression models for predicting insulin resistance (HOMA-IR > 2)
Variable b Standard
error
P Odds ratio 95% confidence interval
Model 1
Intercept -1.642 0.135 < 0.001
TG/HDL-C 0.257 0.042 < 0.001 1.29 1.19-1.41
Model 2
Intercept -7.941 0.986 < 0.001
Sex
Male 1
Female 0.933 0.207 < 0.001 2.54 1.70-3.84
Waist circumference (cm) 0.071 0.012 < 0.001 1.07 1.05-1.10
ALT (mg/dL) 0.015 0.004 < 0.001 1.01 1.01-1.02
TG/HDL-C 0.173 0.044 < 0.001 1.19 1.09-1.30
TG/HDL-C: triglyceride to high-density lipoprotein cholesterol ratio
ALT: alanine transaminase
Figure 1 The receiver operating characteristics curve between
the two models. Model 1 was obtained from the logistic
regression of triglyceride-to-high-density lipoprotein cholesterol ratio
(TG/HDL-C) with the area under the curve = 0.66; Model 2 was
obtained from the multiple logistic regression with the area under
the curve = 0.71. The P-value of the differences between the two
areas was 0.007.
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additional evaluation. Second, the applicability of the
model is limited to the observed data range of the pre-
sent study.
Conclusions
Insulin resistance is the core of the metabolic syndrome
and a pre-diabetes condition. The present study demon-
strated that the diagnostic accuracy of insulin resistance,
defined by HOMA-IR, using TG/HDL-C can be signifi-
cantly enhanced in the prediction model by including
sex, waist circumference, and ALT, which are readily
available clinical measurements. The model described in
this report could be served as a tool to assist health care
professionals to easily and accurately predict insulin
resistance and thereby providing timely lifestyle modifi-
cations advice to susceptible individuals.
Appendix 1
Programming code in R, Microsoft Excel and OpenOf-
fice Calc for calculating the probability of elevated insu-
lin resistance (HOMA-IR > 2) based on the multiple
logistic regression model.
1. In R environment
To calculate the probability of insulin resistance
(HOMA-IR > 2), substitute the values for the variables
X1 to X4 in the following regression equation:
yhat < - (-7.941 # constant
+0 . 9 3 3 * X 1 #X1 = sex (female =
1, male = 0)
+ 0.071*X2 #X2 = waist circum-
ference (cm)
+ 0.015*X3 #X3 = ALT (mg/dL)
+ 0.173*X4 #X4 = TG/HDL-C
)
phat < - 1/(exp(-(yhat))+1)
phat # copy these syntax
and paste on the R console
2. In Microsoft Excel or OpenOffice Calc
Key in the values for sex (female = 1, male = 0) in the
A1 cell, waist circumference (cm) in the A2 cell, ALT
(mg/dL) in the A3 cell, and TG/HDL-C in the A4 cell.
Key in the following formula in any empty cell on the
spreadsheet to obtain the probability of insulin resis-
tance.
=1 / E X P ( −(−7.941 + 0.933 ∗ A 1+0 . 0 7 1∗ A 2+0 . 0 1 5∗ A3 + 0.173 ∗ A4) + 1)
Note: The model should only be applied to individuals
with waist circumference between 57.1 cm and 111.8
cm, ALT between 8 mg/dL and 526 mg/dL, and TG/
HDL-C between 0.26 and 22.26.
Abbreviations
HOMA-IR: homeostasis model assessment for insulin resistance; TG/HDL-C:
triglyceride to high-density lipoprotein cholesterol ratio
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